Klar Yaggi, Director of the Yale Centers for Sleep Medicine and a person living with obstructive sleep apnea, shares his personal experience with Tirzepatide (Zepbound), the first GLP-1 medication FDA-approved for people with both sleep apnea and obesity
Each injection should contain the correct proportional amount
Instead of relying on trends or generic advice, patients receive oversight from a health care provider trained to identify why weight gain occurs and how to address it safely
After that, Eli Lilly would need to submit a New Drug Application to the FDA in the US, and separately apply to the TGA in Australia
After the completion of full-text screening, a manual search was conducted to identify additional articles for inclusion
Croonquist PA, Van Ness B